Compile Data Set for Download or QSAR
Report error Found 19 Enz. Inhib. hit(s) with all data for entry = 11900
TargetDNA-dependent protein kinase catalytic subunit(Human)
Shandong Xuanzhu Pharma Co.

US Patent
LigandPNGBDBM658647(US20240083917, Compound 7-1)
Affinity DataIC50: 0.620nMAssay Description:1. Preparation of 1-Fold Kinase Buffer1) 1-fold kinase buffer40 mM Tris, pH 7.50.0055% Brij-3520 mM MgCl2 0.05 mM DTT2. Compound Preparation1) The de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
Go to US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Shandong Xuanzhu Pharma Co.

US Patent
LigandPNGBDBM658648(US20240083917, Compound 7-2)
Affinity DataIC50: 0.720nMAssay Description:1. Preparation of 1-Fold Kinase Buffer1) 1-fold kinase buffer40 mM Tris, pH 7.50.0055% Brij-3520 mM MgCl2 0.05 mM DTT2. Compound Preparation1) The de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
Go to US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Shandong Xuanzhu Pharma Co.

US Patent
LigandPNGBDBM658644(US20240083917, Compound 4)
Affinity DataIC50: 0.800nMAssay Description:1. Preparation of 1-Fold Kinase Buffer1) 1-fold kinase buffer40 mM Tris, pH 7.50.0055% Brij-3520 mM MgCl2 0.05 mM DTT2. Compound Preparation1) The de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
Go to US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Shandong Xuanzhu Pharma Co.

US Patent
LigandPNGBDBM658641(US20240083917, Compound 1)
Affinity DataIC50: 0.820nMAssay Description:1. Preparation of 1-Fold Kinase Buffer1) 1-fold kinase buffer40 mM Tris, pH 7.50.0055% Brij-3520 mM MgCl2 0.05 mM DTT2. Compound Preparation1) The de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
Go to US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Shandong Xuanzhu Pharma Co.

US Patent
LigandPNGBDBM658649(US20240083917, Compound 8)
Affinity DataIC50: 0.890nMAssay Description:1. Preparation of 1-Fold Kinase Buffer1) 1-fold kinase buffer40 mM Tris, pH 7.50.0055% Brij-3520 mM MgCl2 0.05 mM DTT2. Compound Preparation1) The de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
Go to US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Shandong Xuanzhu Pharma Co.

US Patent
LigandPNGBDBM658657(US20240083917, Compound 19-1)
Affinity DataIC50: 1.10nMAssay Description:1. Preparation of 1-Fold Kinase Buffer1) 1-fold kinase buffer40 mM Tris, pH 7.50.0055% Brij-3520 mM MgCl2 0.05 mM DTT2. Compound Preparation1) The de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
Go to US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Shandong Xuanzhu Pharma Co.

US Patent
LigandPNGBDBM658651(US20240083917, Compound 15-1)
Affinity DataIC50: 1.37nMAssay Description:1. Preparation of 1-Fold Kinase Buffer1) 1-fold kinase buffer40 mM Tris, pH 7.50.0055% Brij-3520 mM MgCl2 0.05 mM DTT2. Compound Preparation1) The de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
Go to US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Shandong Xuanzhu Pharma Co.

US Patent
LigandPNGBDBM658655(Preparation of 5′-methyl-N-(7-methyl-[1,2,4]...)
Affinity DataIC50: 1.40nMAssay Description:1. Preparation of 1-Fold Kinase Buffer1) 1-fold kinase buffer40 mM Tris, pH 7.50.0055% Brij-3520 mM MgCl2 0.05 mM DTT2. Compound Preparation1) The de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
Go to US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Shandong Xuanzhu Pharma Co.

US Patent
LigandPNGBDBM658656(US20240083917, Compound 19)
Affinity DataIC50: 1.60nMAssay Description:1. Preparation of 1-Fold Kinase Buffer1) 1-fold kinase buffer40 mM Tris, pH 7.50.0055% Brij-3520 mM MgCl2 0.05 mM DTT2. Compound Preparation1) The de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
Go to US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Shandong Xuanzhu Pharma Co.

US Patent
LigandPNGBDBM658645(US20240083917, Compound 5)
Affinity DataIC50: 1.63nMAssay Description:1. Preparation of 1-Fold Kinase Buffer1) 1-fold kinase buffer40 mM Tris, pH 7.50.0055% Brij-3520 mM MgCl2 0.05 mM DTT2. Compound Preparation1) The de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
Go to US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Shandong Xuanzhu Pharma Co.

US Patent
LigandPNGBDBM658658(US20240083917, Compound 19-2)
Affinity DataIC50: 1.70nMAssay Description:1. Preparation of 1-Fold Kinase Buffer1) 1-fold kinase buffer40 mM Tris, pH 7.50.0055% Brij-3520 mM MgCl2 0.05 mM DTT2. Compound Preparation1) The de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
Go to US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Shandong Xuanzhu Pharma Co.

US Patent
LigandPNGBDBM658653(US20240083917, Compound 16-2)
Affinity DataIC50: 2.20nMAssay Description:1. Preparation of 1-Fold Kinase Buffer1) 1-fold kinase buffer40 mM Tris, pH 7.50.0055% Brij-3520 mM MgCl2 0.05 mM DTT2. Compound Preparation1) The de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
Go to US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Shandong Xuanzhu Pharma Co.

US Patent
LigandPNGBDBM658652(US20240083917, Compound 16-1)
Affinity DataIC50: 3nMAssay Description:1. Preparation of 1-Fold Kinase Buffer1) 1-fold kinase buffer40 mM Tris, pH 7.50.0055% Brij-3520 mM MgCl2 0.05 mM DTT2. Compound Preparation1) The de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
Go to US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Shandong Xuanzhu Pharma Co.

US Patent
LigandPNGBDBM658646(US20240083917, Compound 6)
Affinity DataIC50: 4.80nMAssay Description:1. Preparation of 1-Fold Kinase Buffer1) 1-fold kinase buffer40 mM Tris, pH 7.50.0055% Brij-3520 mM MgCl2 0.05 mM DTT2. Compound Preparation1) The de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
Go to US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Shandong Xuanzhu Pharma Co.

US Patent
LigandPNGBDBM658654(US20240083917, Compound 17)
Affinity DataIC50: 9.80nMAssay Description:1. Preparation of 1-Fold Kinase Buffer1) 1-fold kinase buffer40 mM Tris, pH 7.50.0055% Brij-3520 mM MgCl2 0.05 mM DTT2. Compound Preparation1) The de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
Go to US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Shandong Xuanzhu Pharma Co.

US Patent
LigandPNGBDBM658643(US20240083917, Compound 3)
Affinity DataIC50: 10.6nMAssay Description:1. Preparation of 1-Fold Kinase Buffer1) 1-fold kinase buffer40 mM Tris, pH 7.50.0055% Brij-3520 mM MgCl2 0.05 mM DTT2. Compound Preparation1) The de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
Go to US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Shandong Xuanzhu Pharma Co.

US Patent
LigandPNGBDBM658659(US20240083917, Compound 20)
Affinity DataIC50: 18.7nMAssay Description:1. Preparation of 1-Fold Kinase Buffer1) 1-fold kinase buffer40 mM Tris, pH 7.50.0055% Brij-3520 mM MgCl2 0.05 mM DTT2. Compound Preparation1) The de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
Go to US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Shandong Xuanzhu Pharma Co.

US Patent
LigandPNGBDBM658650(US20240083917, Compound 9)
Affinity DataIC50: 21nMAssay Description:1. Preparation of 1-Fold Kinase Buffer1) 1-fold kinase buffer40 mM Tris, pH 7.50.0055% Brij-3520 mM MgCl2 0.05 mM DTT2. Compound Preparation1) The de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
Go to US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Shandong Xuanzhu Pharma Co.

US Patent
LigandPNGBDBM658642(US20240083917, Compound 2)
Affinity DataIC50: 22nMAssay Description:1. Preparation of 1-Fold Kinase Buffer1) 1-fold kinase buffer40 mM Tris, pH 7.50.0055% Brij-3520 mM MgCl2 0.05 mM DTT2. Compound Preparation1) The de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
Go to US Patent